Open access · OA
via OpenAlex
The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease
Tsuyoshi Shirai, Rafal R. Nazarewicz, Barbara B. Wallis, Rolando E. Yanes, Ryu Watanabe, Marc Hilhorst, Lü Tian, David G. Harrison, John C. Giacomini, Themistocles L. Assimes, Jörg J. Goronzy, Cornelia M. Weyand
The Journal of Experimental Medicine · 2016 · ▲ 544 citations
Abstract
Abnormal glucose metabolism and enhanced oxidative stress accelerate cardiovascular disease, a chronic inflammatory condition causing high morbidity and mortality. Here, we report that in monocytes and macrophages of patients with atherosclerotic coronary artery disease (CAD), overutilization of glucose promotes excessive and prolonged production of the cytokines IL-6 and IL-1β, driving systemic and tissue inflammation. In patient-derived monocytes and macrophages, increased glucose uptake and glycolytic flux fuel the generation of mitochondrial reactive oxygen species, which in turn promote dimerization of the glycolytic enzyme pyruvate kinase M2 (PKM2) and enable its nuclear translocation. Nuclear PKM2 functions as a protein kinase that phosphorylates the transcription factor STAT3, thus boosting IL-6 and IL-1β production. Reducing glycolysis, scavenging superoxide and enforcing PKM2 tetramerization correct the proinflammatory phenotype of CAD macrophages. In essence, PKM2 serves a previously unidentified role as a molecular integrator of metabolic dysfunction, oxidative stress and tissue inflammation and represents a novel therapeutic target in cardiovascular disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1084/jem.20150900
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Shirai, T., Nazarewicz, R.R., Wallis, B.B., Yanes, R.E., Watanabe, R., Hilhorst, M., Tian, L., Harrison, D.G., Giacomini, J.C., Assimes, T.L., Goronzy, J.J., & Weyand, C.M. (2016). The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. <em>The Journal of Experimental Medicine</em>. https://doi.org/10.1084/jem.20150900
Vancouver
Shirai T, Nazarewicz RR, Wallis BB, Yanes RE, Watanabe R, Hilhorst M, et al. The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. The Journal of Experimental Medicine. 2016. doi:10.1084/jem.20150900.
BibTeX
@article{tsuyoshi2016Thegly,
title = {The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease},
author = {Tsuyoshi Shirai and Rafal R. Nazarewicz and Barbara B. Wallis and Rolando E. Yanes and Ryu Watanabe and Marc Hilhorst and Lü Tian and David G. Harrison and John C. Giacomini and Themistocles L. Assimes and Jörg J. Goronzy and Cornelia M. Weyand},
journal = {The Journal of Experimental Medicine},
year = {2016},
doi = {10.1084/jem.20150900},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Journal of Clinical Endocrinology & Metabolism 2004
Open access · OA
Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk
American Journal of Kidney Diseases 2007
Citation only
Association of Carotid Intima-Medial Thickness and Indices of Arterial Stiffness With Cardiovascular Disease Outcomes in CKD
Circulation Research 2008
Open access · OA
Role of Mitochondrial Dysfunction in Insulin Resistance
Biomolecules & Therapeutics 2017
Preprint · CC-BY
Spermidine Protects against Oxidative Stress in Inflammation Models Using Macrophages and Zebrafish
BioMed Research International 2014
Open access · CC-BY
The Role of Oxidative Stress and Inflammation in Cardiovascular Aging
International Journal of Molecular Sciences 2023
Open access · CC-BY